Keywords
Developing Countries, Perinatal Death, Pre-eclampsia, Pregnancy
Complications, Pregnancy Outcome.
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
3
MAIN TEXT
1. Introduction
Pregnancy, while a transformative phase in a woman's life, can be complicated by
conditions that pose significant risks to both mother and child 1. Hypertensive
disorders of pregnancy, particularly pre-eclampsia (PE), are major contributors to
maternal and perinatal morbidity and mortality globally 2. PE is typically
characterized by new-onset hypertension after 20 weeks of gestation accompanied
by proteinuria or other evidence of maternal end-organ or uteroplacental
dysfunction 3. It affects an estimated 2% to 10% of pregnancies worldwide, with
20% of the total global PE patients belong to the underdeveloped nations 2, 4. The
burden of PE is disproportionately high in developing countries, which may range
from 2% to 17% due to challenges in healthcare infrastructure and management of
complications 5, 6.
Bangladesh has made significant progress in reducing overall maternal
mortality in recent decades. However, the prevalence of PE is 14.4% in
Bangladesh which is much higher compared to the global percentage
7. According
to Bangladesh Maternal Mortality and Health Care Surveys (BMMSs) 2016, the
preeclampsia/eclampsia-specific mortality ratio was 46 per 100,000 live births, 8.
Moreover, 9% of stillbirths and 7% of early neonatal deaths in Bangladesh was
attributed to eclampsia, the severe progression of PE
9. PE remains a formidable
challenge, accounting for nearly one-fourth of all maternal deaths and ranking as
the second most common direct cause of maternal mortality in Bangladesh 8.
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
4
The classification of PE into early-onset (EO-PE, typically occurring <34 weeks
of gestation) and late-onset (LO-PE, occurring ≥ 34 weeks of gestation) has gained
prominence due to its significant prognostic implications 10, 11. EO-PE is often
associated with more severe underlying placental pathology, leading to more
severe clinical manifestations and poorer outcomes for both mother and fetus
compared to LO-PE 12, 13. Understanding these distinctions is critical for risk
stratification, targeted interventions, and optimizing resource allocation.
Despite the recognized importance of this classification, there is a relative
scarcity of studies directly comparing maternal and fetal outcomes between EO-PE
and LO-PE groups within the context of Bangladesh and other developing
countries. Existing local data do not stratify by onset timing, limiting the ability to
tailor management strategies effectively. A better understanding of PE, including its
varying clinical presentations and outcomes based on the timing of onset, is
essential for improving maternal and perinatal health. Therefore, this study aimed
to compare the maternal, fetal, and neonatal outcomes of early versus late-onset
PE among women managed at a tertiary referral hospital in Faridpur, Bangladesh.
2. Methods
2.1 Study Design and Setting
This cross-sectional study was conducted at the Department of Obstetrics and
Gynecology, Faridpur Medical College Hospital (FMCH) in Faridpur, Bangladesh.
FMCH is a tertiary level hospital serving as a major referral center for public and
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
5
private hospitals in Faridpur and adjacent districts including Rajbari, Gopalganj,
Magura, and Madaripur.
2.2 Study Population and Sampling
We reviewed hospital admission records of all pregnant women admitted and
delivered at FMCH between March 2023 and August 2023. Women diagnosed with
PE according to the American College of Obstetricians and Gynecologists (ACOG)
guidelines were considered eligible
3.
Inclusion criteria for participants were: women of reproductive age ranging
between 18-45 years, a complete hospital record (including pregnancy, delivery,
and neonatal details) and availability of contact information for follow-up. Patients
whose pregnancy with PE was terminated before the age of fetal viability (defined
as <28 weeks of gestation) and those without significant hospital record data or
unavailable contact information were excluded. PE was categorized as early-onset
(EO-PE) if diagnosed before 34 completed weeks of gestation and late-onset (LO-
PE) if diagnosed at or after 34 completed weeks of gestation
10.
2.3 Data Collection
Socio-demographic information (e.g., age, education, occupation, residence,
religion), and other clinical history were collected through telephone interviews.
Clinical information, including antenatal care (ANC) and obstetric history,
pregnancy complications, maternal outcome, were primarily extracted from hospital
medical records using a standardized data abstraction form. Fetal and neonatal
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
6
outcomes such as prematurity, low birth weight (LBW), Intrauterine Growth
Restriction (IUGR), congenital anomalies, Apgar scores, need for hospital
admission, respiratory support, neonatal death were also collected from the
records. The data collection was conducted by two trained data collectors using a
pre-structured and pre-tested questionnaire.
2.4 Data Analysis
Collected data were rechecked for errors and cleaned using Microsoft Excel
(version 16.72). Statistical analysis was performed using STATA version 14.2
(StataCorp, College Station, Texas, USA). Descriptive statistics were used to
summarize participant characteristics. Categorical data were presented as
frequencies and percentages, and comparisons between EO-PE and LO-PE
groups were made using the Chi-square test or Fisher's exact test where
appropriate. Continuous data were presented as mean ± standard deviation (SD),
and comparisons were made using the independent samples t-test. A p-value
<0.05 was considered statistically significant.
2.5 Ethical Considerations
Ethical approval for this study was obtained from the Institutional Review Board
(IRB) of Faridpur Medical College Hospital, Faridpur. Informed verbal consent was
obtained from participants prior to conducting the telephone interviews. All data
collected were anonymized prior to analysis.
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
7
3. Results
3.1 Participant Recruitment and Baseline Characteristics
During the six-month study period (March to August 2023), a total of 3785 pregnant
women were delivered at the Department of Gynaecology and Obstetrics, FMCH,
Faridpur. Among them, 427 (11%) mothers were diagnosed with PE. 89 cases
were excluded due to the unavailability of significant clinical records, and an
additional 41 cases were excluded as our data collectors were unable to contact
them. From the eligible cases, 255 women with PE agreed to participate and
provide further information. This final sample comprised 121 women in the EO-PE
group and 134 women in the LO-PE group. (Figure 1)
Figure 1: Flowchart of participant selection from admitted pre-eclamptic patients
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
8
The mean age of the patients was 26.48 ± 6.02 years, with women in the EO-
PE group being older in age compared to the LO-PE group (27.85 ± 5.63 years vs
25.18 ± 6.10 years, p=0.003). While the majority of participants had attained only
up to primary level education, the overall educational level was significantly higher
in the LO-PE group (p=0.016). Approximately 80% of participants were
homemakers. However, being a student was significantly more common in the LO-
PE group compared to the EO-PE group (15.67% vs. 8.26%, p=0.03). About 95%
of participants were Muslim, and approximately two-thirds resided in rural areas,
with no significant difference between groups. A significantly higher percentage of
women in the EO-PE group resided outside Faridpur district compared to the LO-
PE group (62.81% vs. 44.03%, p=0.003). (Table 1)
Table-1: Comparison of socio-demographic factors between EO-PE & LO-PE groups
Characteristics EO-PE (n=121) LO-PE (n=134) P-value
Frequency Percentage Frequency Percentage
Age (Mean ± SD) 27.85 ± 5.63 25.18 ± 6.10 0.003*
Education Level: 0.016*
- Illiterate 11 9.09 % 9 6.72 %
- Able to read/write 18 14.88 % 6 4.48 %
- Primary 45 37.19 % 44 32.84 %
- Secondary 16 13.22 % 30 22.39 %
- Undergraduate 23 19.01 % 27 20.15 %
- Graduate & above 8 6.61 % 18 13.43 %
Occupation: 0.03*
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
9
- Homemaker 101 83.47 % 105 78.36 %
- Business 8 6.61 % 2 1.49 %
- Student 10 8.26 % 21 15.67 %
- Service holder 2 1.65 % 6 4.48 %
Religion: 0.455
- Islam 113 93.39 % 128 95.52 %
- Hinduism 8 6.61 % 6 4.48 %
Residence: 0.003*
- In Faridpur district 45 37.19 % 75 55.97 %
- Outside Faridpur 76 62.81 % 59 44.03 %
Living Area: 0.731
- Rural 88 72.73 % 100 74.63 %
- Urban 33 27.27 % 34 26.27 %
* P-value <0.05 – statistically significant.
3.2 Maternal Clinical History and ANC
A significantly higher proportion of the EO-PE women were primigravid compared
to the LO-PE group (76.03% vs. 47.76%, p<0.001). Pre-existing chronic
hypertension (14.88% vs 5.97%, p=0.019) and hypothyroidism (14.05% vs. 1.49%,
p<0.001) had significantly higher prevalence in the EO-PE group as well. There
were no significant differences between groups in the prevalence of gestational
diabetes mellitus or a family history of hypertension.
Regarding ANC, more than half of all participants did not complete the
minimum recommended four ANC visits. There was no significant difference in
achieving
≥ 4 ANC visits between the LO-PE group and the EO-PE group (44.78%
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
10
vs. 35.54%, p=0.277). Similarly, no significant difference was observed in the
history of PE in previous pregnancies among multigravida women (17.39% vs.
12.50%, p=0.405). (Table 2)
Table 2: Comparison of clinical characteristics between the EO-PE and LO-PE groups
Characteristics EO-PE (n=121) LO-PE (n=134) P-value
Frequency Percentage Frequency Percentage
Primigravida 92 76.03 % 64 47.76 % <0.001*
Gestational Diabetes
Mellitus
8 6.61 % 8 5.97 % 0.833
Hypothyroidism 17 14.05 % 2 1.49 % <0.001*
Chronic Hypertension 18 14.88 % 8 5.97 % 0.019*
History of PE in previous
pregnancies
16 (n= 92) 17.39 % 8 (n=64) 12.50 % 0.405
Family history of
Hypertension
48 39.67 % 51 38.06 % 0.792
ANC (Minimum 4 visits) 43 35.54 % 60 44.78 % 0.277
* P-value <0.05 – statistically significant.
3.3 Maternal Outcomes and Complications
Maternal mortality did not differ significantly between the groups (3.31% in EO-PE
vs. 1.49% in LO-PE, p=0.340). However, specific maternal complications were
more frequent in the EO-PE group. PE progressed to eclampsia in 31.40% of EO-
PE cases compared to 18.66% in LO-PE cases (p=0.018). Placental abruption was
also more common in the EO-PE group (19.83% vs 9.70%, p=0.022). The
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
11
occurrence of other severe maternal complications such as HELLP syndrome,
postpartum hemorrhage (PPH), acute kidney injury (AKI), cerebrovascular
accidents or pulmonary edema had no significant differences between the groups.
The overall prevalence of adverse maternal outcome (defined as one or more
maternal complications or maternal death) was slightly higher in the EO-PE group
(47.11%) compared to the LO-PE group (44.78%, p=0.709). Interestingly, women
in the LO-PE group had a significantly higher rate of cesarean sections (C/S)
compared to those in the EO-PE group (84.33% vs 51.24%, p<0.001). (Table 3)
Table 3: Comparison of maternal outcomes between the EO-PE and LO-PE groups
Characteristics EO-PE (n=121) LO-PE (n=134) p value
Frequency Percentage Frequency Percentage
Mode of delivery:
- NVD 59 48.76 % 21 15.67 % <0.001*
- C/S 62 51.24 % 113 84.33 %
Maternal outcome:
- Maternal death 4 3.31 % 2 1.49 % 0.340
Complications:
Eclampsia 38 31.40 % 25 18.66 % 0.018*
HELLP Syndrome 10 8.26 % 10 7.46 % 0.812
Abruptio Placenta 24 19.83 % 13 9.70 % 0.022*
Postpartum hemorrhage 6 4.96 % 12 8.96 % 0.213
Acute Kidney Injury 4 3.31 % 2 1.49 % 0.340
Cerebrovascular accidents 8 6.61 % 8 5.97 % 0.833
Pulmonary edema 8 6.61 % 4 2.99 % 0.172
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
12
Maternal adverse outcome
a
57 47.11 % 60 44.78 % 0.709
* P-value <0.05 – statistically significant.
a Maternal adverse outcome was defined as occurrence of one or more maternal complications or
maternal death.
3.4 Fetal and Neonatal Outcomes
The EO-PE group experienced significantly poorer fetal outcomes. Fetal survival
(resulting in a livebirth) was markedly lower in the EO-PE group (72%; 87 livebirths
out of 121 cases) compared to the LO-PE group (97%; 130 livebirths out of 134
cases, p<0.001). The sex distribution of infants did not differ significantly between
the groups. (Table 4)
Table 4: Comparison of fetal outcomes between the EO-PE and LO-PE groups
Characteristics EO-PE (n=121) LO-PE (n=134) P-value
Frequency Percentage Frequency Percentage
Fetal outcome: <0.001*
- Livebirth 87 71.90 % 130 97.01 %
- Stillbirth 34 28.10 % 4 2.99 %
Baby Sex: 0.200
- Male 58 47.93 % 75 55.97 %
- Female 63 52.07 % 59 44.03 %
* P-value <0.05 – statistically significant.
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
13
In terms of neonatal outcomes, those born to mothers with EO-PE had
substantially worse outcomes. Women in the EO-PE group (75.86%) had five times
more premature (<37 weeks) deliveries compared to the LO-PE group (13.07%,
p<0.001). Similarly, low birth weight babies (<2500g) were about four times more
frequent in the EO-PE group (73.56%) than in the LO-PE group (17.69%, p<0.001).
IUGR was also significantly more common in neonates from the EO-PE group
(29.89% vs 14.62%, p=0.007).
The need for neonatal hospital admission was significantly higher for neonates
in the EO-PE group compared to the LO-PE group (54.02% vs. 20.77%, p<0.001).
Neonatal death occurred significantly more often in the EO-PE group (11 deaths,
12.64%) compared to the LO-PE group (2 deaths, 1.54%, p=0.001). The difference
in the proportion of neonates with a 5-minute Apgar score and the number of cases
of congenital anomalies between the EO-PE and LO-PE groups was not
significant. Overall, the neonatal adverse outcome (defined as the occurrence of at
least one or more neonatal complications or neonatal death) was alarmingly higher
in the EO-PE group compared to the LO-PE group (89.66% vs. 25.38%, p<0.001).
(Table 5)
Table 5: Comparison of neonatal outcomes between the EO-PE and LO-PE groups
Characteristics EO-PE (n=87) LO-PE (n=130) P-value
Frequency Percentage Frequency Percentage
Prematurity (<37 weeks) 66 75.86 % 17 13.07 % <0.001*
LBW (<2500 g) 64 73.56 % 23 17.69 % <0.001*
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
14
IUGR 26 29.89 % 19 14.62 % 0.007*
Congenital Anomaly 0 0.00 % 4 3.08 % 0.099
Hospital Admission 47 54.02 % 27 20.77 % <0.001*
5-minute APGAR Score
<7
12 13.79 % 10 7.69 % 0.145
Neonatal Death 11 12.64 % 2 1.54 % 0.001*
Neonatal adverse
outcome a
78 89.66 % 33 25.38 % <0.001*
* P-value <0.05 – statistically significant.
a Neonatal adverse outcome was defined as the occurrence of one or more neonatal complications
or neonatal death.
4. Discussion
This study showed that early-onset PE was associated with more severe maternal
complications such as eclampsia and placental abruption, and substantially worse
perinatal outcomes including higher rates of stillbirth, prematurity, low birth weight
and neonatal mortality. Our findings align with previous research suggesting that
early-onset PE (EO-PE) represents a more severe form of the disorder
12-15.
The observed prevalence of PE (11.28%) among admitted pregnant women in
our study is consistent with reports from some other studies in the region. Recent
facility-based studies in Nepal and Bangladesh reported the prevalence of PE as
12% and 14% respectively 16, 17. This high prevalence in tertiary centers is likely
indicative of referral bias, where complicated cases are disproportionately
represented. Such tertiary centers should be adequately resourced with
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
15
specialized personnel and infrastructure to handle the high volume of these
patients.
Studies have consistently shown that women with EO-PE have a higher
incidence of severe maternal complications 18-20. In our study, EO-PE was
associated with significantly higher rates of eclampsia and placental abruption.
Similarly, a study in India found higher rates of eclampsia (43% vs. 28%) and
abruptio placentae (14.4% vs. 12%) in the EO-PE group compared to the LO-PE
group
21 The underlying cause of these poor outcomes lies in the defective
placentation that occurs early in pregnancy, leading to inadequate spiral artery
remodeling, uteroplacental ischemia, and a surge of anti-angiogenic factors into
the maternal bloodstream
13, 22. These factors contribute to widespread endothelial
dysfunction. Given its severity, EO-PE should be treated as a high-risk condition
that requires close monitoring and care in specialized settings. Improving early
screening and educating women about warning signs during pregnancy could help
reduce serious maternal complications.
Interestingly, our study found a significantly higher rate of Cesarean sections in
the LO-PE group. This contrasts with some studies that show no difference or
higher rates in EO-PE due to urgency [17,19]. The difference observed in our
study may be influenced by local clinical practices and the specific thresholds used
for obstetric interventions, such as decisions around the mode and timing of
delivery. This highlights the need for clear institutional guidelines for the timing and
mode of delivery in both PE phenotypes.
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
16
This study reported that EO-PE was associated with poorer fetal survival and
increased rates of prematurity, low birth weight, IUGR and neonatal death. These
adverse neonatal outcomes reflect the severe uteroplacental insufficiency
characteristic of EO-PE, where the placenta fails to develop properly early in
pregnancy
13. As a result, it cannot provide adequate oxygen and nutrients to the
fetus 23. This dysfunctional placenta poses serious risks to both the baby and the
mother. To protect the mother’s health, doctors often need to deliver the baby
prematurely through iatrogenic preterm birth. While this can be life-saving for the
mother, it results in neonatal prematurity and its associated complications such as
breathing difficulties, feeding problems, and long-term disability
24, 25. This
pathophysiology justifies the higher rate of hospitalization and neonatal mortality
among children born to mothers with EO-PE, which was also observed in our
study. Management of these cases must occur exclusively in integrated tertiary
centers with a Neonatal Intensive Care Unit (NICU). Additionally, specialized
training should be facilitated for healthcare providers for a better maternal and
neonatal outcome.
To the best of our knowledge, this is the first study from Bangladesh to
compare pregnancy outcomes based on the timing of pre-eclampsia onset. An
additional strength lies in the comprehensive evaluation of maternal, fetal, and
neonatal outcomes, enabling a multidimensional understanding of the clinical
burden associated with PE. However, several limitations must be acknowledged.
First, being a single facility based study, the findings may be subject to referral bias
and may not be generalizable to the broader pregnant population in Bangladesh.
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
17
Second, the sample size may have been insufficient to detect significant
differences for less common maternal complications. Third, the collection of socio-
demographic and family history data via phone interview introduces potential for
recall bias, although a pre-structured questionnaire was used to standardize this
process. Future research should include larger, multi-center prospective studies
with adjustment for confounders to further delineate these differences and explore
underlying pathophysiological mechanisms. Longitudinal studies are also needed
to understand the long-term health consequences of EO-PE and LO-PE for both
mothers and their children.
5. Conclusion
This study showed that the timing of PE onset has distinct implications for both
maternal and perinatal outcomes in a tertiary level hospital setting in Bangladesh.
EO-PE showed more adverse maternal and perinatal outcomes. This group is
highly vulnerable and requires close monitoring in well-equipped facilities. Focus
should be given on early screening, health education, and training of the
healthcare providers. Further longitudinal research should be carried out in order to
gain a better understanding of the differential impact of early versus late PE.
References
[1] Poon LC, Shennan A, Hyett JA , et al. The International Federation of
Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic
guide for first trimester screening and prevention. International journal of
gynaecology and obstetrics: the official organ of the International Federation of
Gynaecology and Obstetrics. 2019; 145(Suppl 1): 1.
[2] Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking:
systematic review of controlled studies. BMJ. 2005; 330(7491): 565.
[3] Obstetricians ACo, Gynecologists. Hypertension in pregnancy. Report of the
American College of Obstetricians and Gynecologists’ task force on hypertension
in pregnancy. Obstet Gynecol. 2013; 122: 1122.
[4] Kharaghani R, Cheraghi Z, Esfahani BO, Mohammadian Z, Nooreldinc RS.
Prevalence of preeclampsia and eclampsia in Iran. Arch Iran Med. 2016; 19(1): 0-.
[5] Basso O, Rasmussen S, Weinberg CR, Wilcox AJ, Irgens LM, Skjaerven R.
Trends in fetal and infant survival following preeclampsia. JAMA. 2006; 296(11):
1357-62.
[6] Osungbade KO, Ige OK. Public health perspectives of preeclampsia in
developing countries: implication for health system strengthening. Journal of
pregnancy. 2011; 2011(1): 481095.
[7] Ali A, Islam J, Paul R , et al. Geographic inequalities and determinants of
anaemia among preeclamptic women: a cross-sectional sample-based study in
Bangladesh. BMC Public Health. 2024; 24(1): 1650.
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
19
[8] Khan S, Siddique AB, Jabeen S , et al. Preeclampsia and eclampsia-specific
maternal mortality in Bangladesh: Levels, trends, timing, and care-seeking
practices. Journal of Global Health. 2023; 13: 07003.
[9] Rahman S, Begum N, Mahmud A. Evaluation of Morbidity and Mortality of
Eclampsia at Brahmanbaria Medical College and Hospital. Journal of Rangpur
Medical College. 2024; 9(1): 39-43.
[10] Von Dadelszen P , Magee LA, Roberts JM. Subclassification of
preeclampsia. Hypertens Pregnancy. 2003; 22(2): 143-8.
[11] Roberts CL, Ford JB, Algert CS , et al. Population-based trends in pregnancy
hypertension and pre-eclampsia: an international comparative study. BMJ Open.
2011; 1(1): e000101.
[12] Raymond D, Peterson E. A critical review of early-onset and late-onset
preeclampsia. Obstet Gynecol Surv. 2011; 66(8): 497-506.
[13] Redman C, Sargent I. Placental stress and pre-eclampsia: a revised view.
Placenta. 2009; 30: 38-42.
[14] Valensise H, Vasapollo B, Gagliardi G, Novelli GP . Early and late
preeclampsia: two different maternal hemodynamic states in the latent phase of the
disease. Hypertension. 2008; 52(5): 873-80.
[15] LaMarca BD, Gilbert J, Granger JP. Recent progress toward the
understanding of the pathophysiology of hypertension during preeclampsia.
Hypertension. 2008; 51(4): 982-8.
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
20
[16] Shrestha J, Subedi A, Gauchan E, Shrestha A, Pandey C. Pregnancy
outcome in early versus late onset preeclampsia. Nepal Journal of Obstetrics and
Gynaecology. 2021; 16(2): 53-9.
[17] Mou AD, Barman Z, Hasan M , et al. Prevalence of preeclampsia and the
associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;
11(1): 21339.
[18] Wojtowicz A, Zembala-Szczerba M, Babczyk D, Kołodziejczyk-Pietruszka M,
Lewaczyń ska O, Huras H. Early‐ and late‐ onset preeclampsia: a comprehensive
cohort study of laboratory and clinical findings according to the new ISHHP criteria.
Int J Hypertens. 2019; 2019(1): 4108271.
[19] Wadhwani P, Saha PK, Kalra JK, Gainder S, Sundaram V. A study to
compare maternal and perinatal outcome in early vs. late onset preeclampsia.
Obstetrics & Gynecology Science. 2020; 63(3): 270.
[20] Lisonkova S, Joseph K. Incidence of preeclampsia: risk factors and
outcomes associated with early-versus late-onset disease. Am J Obstet Gynecol.
2013; 209(6): 544. e1-. e12.
[21] Geeta Sri LK, Lakshmi CS. Early and Late Onset Pre-eclampsia – Maternal
and Perinatal Outcome in Tertiary Care Hospital. International Journal of Current
Microbiology and Applied Sciences. 2021; 10(8): 156-63.
[22] Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia:
pathophysiology, challenges, and perspectives. Circ Res. 2019; 124(7): 1094-112.
[23] Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia:
pathophysiology and clinical implications. BMJ. 2019; 366.
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint
21
[24] Madazli R, Yuksel MA, Imamoglu M , et al. Comparison of clinical and
perinatal outcomes in early-and late-onset preeclampsia. Arch Gynecol Obstet.
2014; 290: 53-7.
[25] Schneider H. Placental dysfunction as a key element in the pathogenesis of
preeclampsia. Journal of Mother and Child. 2017; 21(4): 309-16.
. CC-BY 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 17, 2025. ; https://doi.org/10.1101/2025.10.15.25337483doi: medRxiv preprint